Immunocore Holdings Stock Performance

IMCR Stock  USD 33.68  0.75  2.28%   
The company retains a Market Volatility (i.e., Beta) of 0.61, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immunocore Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Immunocore Holdings is expected to be smaller as well. At this point, Immunocore Holdings has a negative expected return of -0.24%. Please make sure to check out Immunocore Holdings' potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Immunocore Holdings performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Immunocore Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in March 2026. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more

Actual Historical Performance (%)

One Day Return
2.28
Five Day Return
1.35
Year To Date Return
(0.30)
Ten Year Return
(22.04)
All Time Return
(22.04)
1
Disposition of 18020 shares by Berman David M of Immunocore Holdings at 40.03 subject to Rule 16b-3
11/25/2025
2
Disposition of 69404 shares by Berman David M of Immunocore Holdings at 40.12 subject to Rule 16b-3
11/26/2025
3
Hudson Bay Capital Management LP Trims Stake in Immunocore Holdings PLC Sponsored ADR IMCR
12/15/2025
4
Disposition of 5521 shares by Berman David M of Immunocore Holdings at 40.09 subject to Rule 16b-3
01/06/2026
5
Immunocore Holdings PLC Sponsored ADR Receives Average Rating of Moderate Buy from Brokerages - MarketBeat
01/15/2026
6
How Immunocore Holdings Plc Affects Rotational Strategy Timing - Stock Traders Daily
01/23/2026
7
Immunocore Holdings is One of the Best Small Cap Stocks Ready to Explode in 2026
01/30/2026
8
A Look At Immunocore Holdings Valuation As Analysts Reassess Pipeline And Leadership Changes
02/04/2026
9
Immunocore Holdings PLC Sponsored ADR IMCR Shares Sold by Principal Financial Group Inc. - MarketBeat
02/10/2026
10
Why Immunocore Holdings plc stock signals breakout potential - 2025 Market Outlook High Yield Equity Trading Tips - mfd.ru
02/13/2026
11
Disposition of 5965 shares by Berman David M of Immunocore Holdings at 32.35 subject to Rule 16b-3
02/18/2026
12
Disposition of 1351 shares by Goll John of Immunocore Holdings subject to Rule 16b-3
02/19/2026
13
Immunocore CEO Bahija Jallal Sells 11,474 Shares of Stock
02/20/2026
14
A Look At Immunocore Holdings Valuation After Mixed Recent Share Price Performance
02/23/2026
Begin Period Cash Flow442.6 M
Total Cashflows From Investing Activities-355.1 M

Immunocore Holdings Relative Risk vs. Return Landscape

If you would invest  3,950  in Immunocore Holdings on November 27, 2025 and sell it today you would lose (582.00) from holding Immunocore Holdings or give up 14.73% of portfolio value over 90 days. Immunocore Holdings is currently does not generate positive expected returns and assumes 2.4532% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than Immunocore, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Immunocore Holdings is expected to under-perform the market. In addition to that, the company is 3.21 times more volatile than its market benchmark. It trades about -0.1 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Immunocore Holdings Target Price Odds to finish over Current Price

The tendency of Immunocore Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 33.68 90 days 33.68 
about 69.78
Based on a normal probability distribution, the odds of Immunocore Holdings to move above the current price in 90 days from now is about 69.78 (This Immunocore Holdings probability density function shows the probability of Immunocore Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Immunocore Holdings has a beta of 0.61. This usually indicates as returns on the market go up, Immunocore Holdings average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Immunocore Holdings will be expected to be much smaller as well. Additionally Immunocore Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Immunocore Holdings Price Density   
       Price  

Predictive Modules for Immunocore Holdings

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immunocore Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunocore Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
31.0633.5135.96
Details
Intrinsic
Valuation
LowRealHigh
30.3142.1344.58
Details
Naive
Forecast
LowNextHigh
31.7234.1736.63
Details
17 Analysts
Consensus
LowTargetHigh
60.5866.5773.89
Details

Immunocore Holdings Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Immunocore Holdings is not an exception. The market had few large corrections towards the Immunocore Holdings' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Immunocore Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Immunocore Holdings within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.22
β
Beta against Dow Jones0.61
σ
Overall volatility
2.47
Ir
Information ratio -0.11

Immunocore Holdings Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immunocore Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immunocore Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Immunocore Holdings generated a negative expected return over the last 90 days
Immunocore Holdings has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 247.77 M. Net Loss for the year was (51.09 M) with profit before overhead, payroll, taxes, and interest of 334.36 M.
Immunocore Holdings has a poor financial position based on the latest SEC disclosures
Over 100.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: A Look At Immunocore Holdings Valuation After Mixed Recent Share Price Performance

Immunocore Holdings Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Immunocore Stock often depends not only on the future outlook of the current and potential Immunocore Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunocore Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding50 M
Cash And Short Term Investments820.4 M

Immunocore Holdings Fundamentals Growth

Immunocore Stock prices reflect investors' perceptions of the future prospects and financial health of Immunocore Holdings, and Immunocore Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immunocore Stock performance.

About Immunocore Holdings Performance

Assessing Immunocore Holdings' fundamental ratios provides investors with valuable insights into Immunocore Holdings' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Immunocore Holdings is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 213.27  367.43 
Return On Tangible Assets(0.04)(0.04)
Return On Capital Employed(0.06)(0.07)
Return On Assets(0.04)(0.04)
Return On Equity(0.10)(0.11)

Things to note about Immunocore Holdings performance evaluation

Checking the ongoing alerts about Immunocore Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immunocore Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Immunocore Holdings generated a negative expected return over the last 90 days
Immunocore Holdings has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 247.77 M. Net Loss for the year was (51.09 M) with profit before overhead, payroll, taxes, and interest of 334.36 M.
Immunocore Holdings has a poor financial position based on the latest SEC disclosures
Over 100.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: A Look At Immunocore Holdings Valuation After Mixed Recent Share Price Performance
Evaluating Immunocore Holdings' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Immunocore Holdings' stock performance include:
  • Analyzing Immunocore Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immunocore Holdings' stock is overvalued or undervalued compared to its peers.
  • Examining Immunocore Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Immunocore Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immunocore Holdings' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Immunocore Holdings' stock. These opinions can provide insight into Immunocore Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Immunocore Holdings' stock performance is not an exact science, and many factors can impact Immunocore Holdings' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Immunocore Stock Analysis

When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.